These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8689815)
21. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans. Okaniwa T; Echizen H; Ishizaki T; Kasao M; Iizuka T J Pharmacol Exp Ther; 1990 Nov; 255(2):716-23. PubMed ID: 2147037 [TBL] [Abstract][Full Text] [Related]
22. The influence of drug input rate on the development of tolerance to frusemide. Wakelkamp M; Alván G; Scheinin H; Gabrielsson J Br J Clin Pharmacol; 1998 Nov; 46(5):479-87. PubMed ID: 9833602 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model. Deschamps C; Dubruc C; Mentre F; Rosenzweig P Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025 [TBL] [Abstract][Full Text] [Related]
24. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis]. Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699 [TBL] [Abstract][Full Text] [Related]
25. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation. van der Vorst MM; Wildschut E; Houmes RJ; Gischler SJ; Kist-van Holthe JE; Burggraaf J; van der Heijden AJ; Tibboel D Crit Care; 2006; 10(6):R168. PubMed ID: 17140428 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580 [TBL] [Abstract][Full Text] [Related]
28. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure. Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787 [TBL] [Abstract][Full Text] [Related]
29. Determinants of the overall response to furosemide: pharmacokinetics and pharmacodynamics. Brater DC Fed Proc; 1983 Apr; 42(6):1711-3. PubMed ID: 6832391 [TBL] [Abstract][Full Text] [Related]
30. Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs. Hori Y; Katou A; Tsubaki M; Kanai K; Nakao R; Hoshi F; Itoh N; Higuchi S Am J Vet Res; 2008 Dec; 69(12):1664-9. PubMed ID: 19046016 [TBL] [Abstract][Full Text] [Related]
31. Development of an optimal furosemide infusion strategy in infants with modeling and simulation. Schoemaker RC; van dDer Vorst MM; van Heel IR; Cohen AF; Burggraaf J; Clin Pharmacol Ther; 2002 Oct; 72(4):383-90. PubMed ID: 12386640 [TBL] [Abstract][Full Text] [Related]
32. NXY-059 does not significantly interact with furosemide in healthy volunteers. Strid S; Nilsson D; Borgå O; Wemer J; Grahnén A J Clin Pharmacol; 2006 Dec; 46(12):1417-25. PubMed ID: 17101741 [TBL] [Abstract][Full Text] [Related]
33. Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters. Lambert C; Larose P; Ong H; Gutkowska J; du Souich P Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):181-99. PubMed ID: 3909271 [TBL] [Abstract][Full Text] [Related]
34. Comparative pharmacokinetics and pharmacodynamics of furosemide in Middle Eastern and in Asian subjects. Abou-Auda HS Int J Clin Pharmacol Ther; 1998 May; 36(5):275-81. PubMed ID: 9629992 [TBL] [Abstract][Full Text] [Related]
35. Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome. Takamura N; Maruyama T; Chosa E; Kawai K; Tsutsumi Y; Uryu Y; Yamasaki K; Deguchi T; Otagiri M Drug Metab Dispos; 2005 Apr; 33(4):596-602. PubMed ID: 15640375 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544 [TBL] [Abstract][Full Text] [Related]
37. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion. Apte Y; Bellomo R; Warrillow S; Goldsmith D; Gillies M; McGain F Crit Care Resusc; 2008 Dec; 10(4):306-11. PubMed ID: 19049481 [TBL] [Abstract][Full Text] [Related]
38. On the mechanism of acute tolerance to furosemide diuresis. Sjöström PA; Odlind BG; Beermann BA; Hammarlund-Udenaes M Scand J Urol Nephrol; 1988; 22(2):133-40. PubMed ID: 3060993 [TBL] [Abstract][Full Text] [Related]
39. Response of renin, aldosterone and antidiuretic hormone to furosemide and furosemide-triamterene combination. Lammintausta R; Anttila M; Viinamäki O Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):395-8. PubMed ID: 7005123 [TBL] [Abstract][Full Text] [Related]
40. Dose-dependent cardiovascular, renal, and endocrine effects of furosemide in conscious lambs. Patel A; Smith FG Can J Physiol Pharmacol; 1997 Sep; 75(9):1101-7. PubMed ID: 9365820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]